spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  head and neck cancer 

 HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2023
ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Apr 2022
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2021
Merck KGaA, Darmstadt, Germany, Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 23 Dec 2020
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 25 Sep 2020
Rakuten Medical Japan Announces Marketing Approval of Akalux(R) IV Infusion 250mg and BioBlade(R) Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2019
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2019
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) THIN LIQUID (barium sulfate) for oral suspension
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2018
Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2018
Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
Devices Oncology
 HSMN NewsFeed - 5 Sep 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Devices Radiology Oncology Venture Capital
 HSMN NewsFeed - 23 Aug 2018
Rakuten Aspyrian Raises $150 Million in Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Aug 2018
Alpha Tau's High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United States
Devices Oncology Regulatory
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2018
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
Devices Oncology Product Launch
 HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2018
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
Devices Oncology Regulatory
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Diagnostics Radiology Gastroenterology FDA
 HSMN NewsFeed - 20 Jul 2017
New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Devices Oncology
 HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jul 2017
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Devices Oncology
 HSMN NewsFeed - 20 Jun 2017
IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
Devices Oncology
 HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Apr 2017
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2017
Advaxis Appoints Anthony Lombardo as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Apr 2017
New ASTRO Guideline Establishes Standard of Care for Curative Treatment of Oropharyngeal Cancer with Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 11 Apr 2017
First Cancer Patients in Africa Treated with the TomoTherapy(R) System
Devices Oncology
 HSMN NewsFeed - 15 Mar 2017
FDA Approves Merck’s KEYTRUDA(R) (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL) Refractory to Treatment, or Who Have Relapsed After Three or More Prior Lines of Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Nov 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2016
Vigilant Biosciences Announces New Distribution Partnership Agreements for OncAlert(R) Oral Cancer Product Line for Spain, Portugal and Germany
Diagnostics Oncology Distribution
 HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Sep 2016
IBA's Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated
Devices Oncology
 HSMN NewsFeed - 12 Sep 2016
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Jul 2016
Advaxis Appoints Ranya Dajani as Vice President, Corporate Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2016
Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Nov 2015
Vigilant Biosciences Announces Distribution Agreements for OncAlert(TM) Oral Cancer System for Czech Republic and Slovakia, Israel and Baltic Region
Diagnostics Oncology Distribution
 HSMN NewsFeed - 16 Nov 2015
Vigilant Biosciences Receives CE Mark for OncAlert(TM) Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer
Diagnostic Oncology Regulatory
 HSMN NewsFeed - 19 Oct 2015
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Oct 2015
Galera Therapeutics Raises $37 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jul 2015
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 12 May 2015
Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Sep 2014
Navidea’s Lymphoseek(R) Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Aug 2014
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 20 Jun 2014
IsoRay Announces New Russian and Peruvian International Distributor Agreements for the Sale of IsoRay's Full Line of Products
Devices Oncology Distribution
 HSMN NewsFeed - 11 Jun 2014
Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2014
Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 12 May 2014
IsoRay's Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
Devices Oncology
 HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology
 HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2013
Swallow Solutions, LLC, Secures $1.046 Million Series A Financing
Devices Venture Capital
 HSMN NewsFeed - 11 Dec 2012
IsoRay's Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to The Society Of Neuro-Oncology
Devices Oncology
 HSMN NewsFeed - 11 Dec 2012
Galera Therapeutics Raises $11 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 8 Oct 2012
Gliknik Raises $4.9 Million In Series B Financing Led By Baxter Ventures
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 4 Jun 2012
Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2012
IsoRay’s GliaSite Approved for Sale in 31 European Countries
Devices Oncology Regulatory
 HSMN NewsFeed - 9 May 2012
Accuray Unveils Enhanced TomoTherapy Treatment Planning System at ESTRO 31
Devices Oncology
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 23 Apr 2012
OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
Devices Drug Delivery Oncology
 HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 12 Sep 2011
FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer
Devices Oncology FDA
 HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
Devices Oncology
 HSMN NewsFeed - 13 Jun 2011
Spectrum Pharmaceuticals Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2011
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex(R) for GliaSite(R) Brain Cancer Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 12 May 2011
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
Devices Oncology
 HSMN NewsFeed - 2 May 2011
TomoHD(TM) Radiation Therapy System Selected by UCSF Medical Center
Devices Oncology
 HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2010
BSD Medical Announces Purchase of BSD-500 Hyperthermia System by University Medical Center of Göttingen, Germany
Devices Oncology
 HSMN NewsFeed - 7 Oct 2010
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
Devices Oncology
 HSMN NewsFeed - 24 Aug 2010
TomoTherapy Enables General Hospital of Guangzhou Military Command of PLA to Provide Advanced Care to Patients With Head and Neck Cancers
Devices Oncology
 HSMN NewsFeed - 15 Jul 2010
Cancer Patients in Scotland Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2010
IRX Therapeutics Appoints Neil L. Berinstein Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2010
BioVex Appoints Tim Hanke as VP Commercial Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Dec 2009
Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 15 Dec 2009
Access Pharmaceuticals Appoints Sales and Marketing Executive
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Nov 2009
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
Devices Oncology
 HSMN NewsFeed - 18 Aug 2009
IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors
Devices Oncology FDA
 HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jul 2009
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Biopharmaceuticals
 HSMN NewsFeed - 23 Jul 2009
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 May 2009
Roswell Park Cancer Institute Leads Radiosurgery Capabilities in New York State with Leksell Gamma Knife Perfexion
Devices Oncology Neurosurgery
 HSMN NewsFeed - 21 Apr 2009
Varian RapidArc Technology Used with Novalis Tx System for First Time Outside U.S. to Treat Head and Neck Cancer Patient
Devices Oncology
 HSMN NewsFeed - 20 Apr 2009
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 31 Mar 2009
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
Biopharmaceuticals
 HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Feb 2009
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jan 2009
GenVec Reduces Costs to Preserve Capital
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Diagnostics Acquisitions
 HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2008
ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Oct 2008
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Sep 2008
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
Devices Neurosurgery
 HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2008
Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
Devices Oncology
 HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Sep 2008
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Jul 2008
ImClone Announces Changes in Commercial Organization Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jul 2008
Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical
Devices Oncology
 HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 16 Jun 2008
IRX Therapeutics Names Scott M. Freeman, M.D. Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2008
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2008
Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
Devices Oncology
 HSMN NewsFeed - 25 Mar 2008
Oncolin Therapeutics Provides a Company Overview
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Mar 2008
EU Commission Approves Updated Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Feb 2008
YM Biosciences USA Enrolls First Patient in Phase II Trial of Nimotuzumab in Children with Inoperable, Recurrent Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jan 2008
Carol R. Epstein, M.D. Joins IRX Therapeutics As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2008
Alfacell Appoints David Sidransky Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2008
Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Devices Oncology FDA
 HSMN NewsFeed - 20 Dec 2007
Introgen Plans to Expand Biomarker Database in Phase 3 Trials and File BLA and MAA for ADVEXIN in Advanced Head and Neck Cancer in First Half of 2008
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Nov 2007
NCCN Receives Major Grant for Anti-Cancer Drug Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Nov 2007
BioVex Closes Second Round of Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Nov 2007
Introgen Therapeutics Highlights Summary ADVEXIN Data at the Third International Workshop on Mutant p53 and the Symposium on Li-Fraumeni Syndrome
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2007
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Nov 2007
Amgen Announces Updates to the U.S. Prescribing Information for ESAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2007
Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007
Devices Oncology
 HSMN NewsFeed - 24 Oct 2007
Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Oct 2007
Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2007
Abraxis BioScience and Biocon Limited Announce Approval of ABRAXANE in India for the Treatment of Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Oct 2007
New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2007
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2007
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Sep 2007
Introgen Presents Biomarker Data Demonstrating Abnormal p53 Predicts ADVEXIN Efficacy in Head and Neck, Lung, Prostate and Li-Fraumeni Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Sep 2007
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2007
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Sep 2007
Vision-Sciences, Inc. Unveils New Video-Based Advanced Endoscopes for Use with its New EndoSheath Technology at World's Largest Gathering of Ear, Nose and Throat Physicians
Devices
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 6 Sep 2007
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2007
YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Aug 2007
Oncoscience Ag, the European Partner of Ym Biosciences, Announces Completion of Patient Enrollment in Phase III Brain Cancer Trial of Nimotuzumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jul 2007
Myriad Genetics Launches New Molecular Diagnostic Test
Diagnostics Oncology
 HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jun 2007
Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstrom's Macroglobulinemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jun 2007
Taxotere(R) (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Prior to Chemoradiotherapy and Surgery
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 27 Jun 2007
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Jun 2007
Inovio Biomedical's Selective Electrochemical Tumor Ablation Therapy Shows Safety, Tolerability, and Significant Complete Responses in Breast Cancer Study
Devices Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jun 2007
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Jun 2007
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Devices Drug Delivery Oncology
 HSMN NewsFeed - 5 Jun 2007
Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2007
OSI Pharmaceuticals Summarizes Data on Tarceva(R) (erlotinib) at the 2007 American Society of Clinical Oncology (ASCO) Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
Cytokinetics Announces the Presentation of Clinical Trials Data at the 2007 Annual Meeting of the American Society of Clinical Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade(TM) at ASCO
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2007
NCCN Updates Head and Neck Cancers Guidelines
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 22 May 2007
Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 9 May 2007
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial
Biopharmacetuicals Oncology
 HSMN NewsFeed - 16 Apr 2007
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Apr 2007
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Apr 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2007
YM BioSciences Strengthens Program Management of Lead Drugs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Feb 2007
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2007
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2007
YM BioSiences Announces Management Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Feb 2007
Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Feb 2007
Inovio Presents MedPulser(R) Electrochemical Tumor Ablation Results at 5th International Symposium on Advances in Head & Neck Cancer
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 30 Jan 2007
YM BioSciences announces termination of the tesmilifene Phase III pivotal trial in advanced breast cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jan 2007
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jan 2007
IRX Therapeutics Names John W. Hadden II President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2007
CEL-SCI Receives Green Light From FDA to Proceed With Phase III Cancer Study
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jan 2007
MedImmune Announces District Court's Rejection of Sun Pharmaceutical's Motion to End Litigation Regarding Generic Amifostine
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jan 2007
Access Pharmaceuticals Names Stephen R. Seiler as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2006
The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2006
Advaxis Names Thomas A. Moore to Serve as CEO and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2006
Introgen Announces New Clinical Data Confirming ADVEXIN(R) Survival Benefit
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Nov 2006
Cytokinetics and GlaxoSmithKline Amend Collaboration and License Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Nov 2006
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
Biopharmaceuticals Oncology Drug Delivery Licensing
 HSMN NewsFeed - 7 Nov 2006
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Oct 2006
Prominent Oncologist, Dr. David Sidransky, Joins Zila Board
Diagnostics Personnel
 HSMN NewsFeed - 31 Oct 2006
Introgen Therapeutics and Gendux AB Announce Agreement With European Medicines Agency to File for ADVEXIN Approval Under Exceptional Circumstance Rules
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Oct 2006
Taxotere(R) Receives U.S. FDA Approval for the Treatment of Patients With Head and Neck Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Oct 2006
Introgen's ADVEXIN Molecular Targeted Therapy Is Active in Multiple Cancers; ADVEXIN Regulatory Program Advances
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Oct 2006
Endo Pharmaceuticals Acquires RxKinetix, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2006
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Jul 2006
IOERT Shown to be Effective in Treating Pancreatic Cancer
Devices Oncology
 HSMN NewsFeed - 2 Jun 2006
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 May 2006
Introgen to Announce Important New Clinical Data for ADVEXIN Cancer Therapy at Major Medical Meetings
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2006
Northwest Biotherapeutics Updates Brain Cancer Clinical Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2006
Advaxis Continues Advancement of Two Listeria Vaccines Targeting Cancers Affecting Women
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2006
Inovio Acquires Intellectual Property Rights to Augment Patent Estate for Electroporation-Assisted DNA Delivery
Biopharmaceuticals Drug Delivery Licensing
Return to NewsFeed  

 Additional items found! 173

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 173 additional stories matching:
head and neck cancer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.